Fosaprepitant dimeglumine

CAS No. 265121-04-8

Fosaprepitant dimeglumine( MK 0517 )

Catalog No. M13812 CAS No. 265121-04-8

Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 43 In Stock
10MG 58 In Stock
25MG 117 In Stock
50MG 207 In Stock
100MG 343 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Fosaprepitant dimeglumine
  • Note
    Research use only, not for human use.
  • Brief Description
    Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.
  • Description
    Fosaprepitant dimeglumine(MK-0517) is a neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.(In Vitro):Fosaprepitant dimeglumine (30 mg/kg; i.p.; daily; for 7 days) attenuates tolerance to morphine and increases the antinociceptive effect in in rats.
  • In Vitro
    ——
  • In Vivo
    Animal Model:Sprague-Dawley rats Dosage:30 mg/kg Administration:Intraperitoneal injection, daily, for 7 days Result:Increased the antinociceptive effect of morphine compared to control group.
  • Synonyms
    MK 0517
  • Pathway
    GPCR/G Protein
  • Target
    Neurokinin Receptor
  • Recptor
    NK1
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    265121-04-8
  • Formula Weight
    1004.83
  • Molecular Formula
    C37H56F7N6O16P
  • Purity
    >98% (HPLC)
  • Solubility
    Water: 135 mg/mL (134.35 mM); DMSO: 201 mg/mL (200.03 mM)
  • SMILES
    C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)N(N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Navari RM. Expert Opin Investig Drugs, 2007, 16(12), 1977-1985.
molnova catalog
related products
  • QWF

    Tripeptide substance P (SP) antagonist (IC50 = 90 μM). Also inhibits binding of SP to Mas-related GPCR (MRGPR) X2. Inhibits SP-induced IgE-independent degranulation of mast cells in vitro. Inhibits compound 48/80-induced MRGPRX2 activation and scratching in mice in vivo.

  • NKP-608

    A non-peptidic, specific, potent and orally active NK1 receptor antagonist with IC50 of 2.6 nM.

  • NIH-12848

    NIH-12848 is a putative inhibitor of phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ) with an IC50 of 1 μM.